[go: up one dir, main page]

AU2001259730A1 - Standardized oxidized ldl assay - Google Patents

Standardized oxidized ldl assay

Info

Publication number
AU2001259730A1
AU2001259730A1 AU2001259730A AU5973001A AU2001259730A1 AU 2001259730 A1 AU2001259730 A1 AU 2001259730A1 AU 2001259730 A AU2001259730 A AU 2001259730A AU 5973001 A AU5973001 A AU 5973001A AU 2001259730 A1 AU2001259730 A1 AU 2001259730A1
Authority
AU
Australia
Prior art keywords
standardized
oxidized ldl
ldl assay
assay
oxidized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259730A
Inventor
Wulf Palinski
Peter X. Shaw
Gregg Silverman
Sotirios Tsimikas
Joseph Witztum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Publication of AU2001259730A1 publication Critical patent/AU2001259730A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001259730A 2000-05-12 2001-05-11 Standardized oxidized ldl assay Abandoned AU2001259730A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20397800P 2000-05-12 2000-05-12
US60/203,978 2000-05-12
PCT/US2001/015214 WO2001088547A2 (en) 2000-05-12 2001-05-11 Standardized oxidized ldl assay

Publications (1)

Publication Number Publication Date
AU2001259730A1 true AU2001259730A1 (en) 2001-11-26

Family

ID=22756083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259730A Abandoned AU2001259730A1 (en) 2000-05-12 2001-05-11 Standardized oxidized ldl assay

Country Status (2)

Country Link
AU (1) AU2001259730A1 (en)
WO (1) WO2001088547A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02004244A (en) * 1999-10-26 2002-11-04 Univ California Reagents and methods for diagnosing, imaging and treating atherosclerotic disease.
AU2005233361B2 (en) 2004-04-15 2011-02-24 Athera Biotechnologies Ab Phosphorylcholine conjugates and corresponding antibodies
RU2410694C2 (en) * 2009-04-01 2011-01-27 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Method of estimating degree of coronary obstruction in patients with ischemic heart disease
US9796786B2 (en) 2011-08-09 2017-10-24 Athera Biotechnologies Ab Antibodies binding to phosphorylcholine (PC) and/or PC conjugates
HK1200852A1 (en) 2011-08-09 2015-08-14 阿瑟拉生物技术公司 New antibodies against phosphorylcholine
CN103630695A (en) * 2013-11-20 2014-03-12 中国人民解放军南京军区南京总医院 Chemiluminiscence imaging immunoassay method for simultaneously measuring oxidized lipoprotein (a) and oxidized low-density lipoprotein of human serum
CN104914255A (en) * 2015-05-21 2015-09-16 北京协和洛克生物技术有限责任公司 Kit for detecting concentration of oxidized low-density lipoprotein in sample and preparation method thereof
CN105974143A (en) * 2016-04-08 2016-09-28 刘庆平 Enzyme-linked immunosorbent assay kit for detection of human oxidized low-density lipoprotein and preparation method thereof
WO2021097379A1 (en) * 2019-11-14 2021-05-20 The Regents Of The University Of California Methods and compositions for determining oxpl-associated diseases and disorders
EP4680632A2 (en) 2023-03-17 2026-01-21 Oxitope Pharma B.V. Anti-phosphocholine antibodies and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2294355C (en) * 1997-06-20 2006-11-28 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins
US6225070B1 (en) * 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma

Also Published As

Publication number Publication date
WO2001088547A3 (en) 2003-01-30
WO2001088547A2 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AUPR005600A0 (en) Diagnostic assay
AU2001229735A1 (en) Position assisted service selection
AU2002213400A1 (en) Microvalve
AU2001286051A1 (en) Microfluidic
AU2002218331A1 (en) Bioanalytical assay
AU2001266490A1 (en) One aperture simultaneous rx-tx-antenna
AU2002353861A1 (en) Assay
AU2001259730A1 (en) Standardized oxidized ldl assay
AUPQ504000A0 (en) Brake assembly
AUPQ943700A0 (en) Micronucleus assay
AUPQ958200A0 (en) Coupling assembly
AU7626201A (en) Stage construction
AU2001232041A1 (en) Improved assay
AU2001232132A1 (en) Novel assay
AU4670901A (en) Homocysteine assay
AU7537400A (en) Assay
AU2001240793A1 (en) Novel assay
AU5240901A (en) Assay
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
AU2001278639A1 (en) Winch assembly
AU2000268216A1 (en) Service broker
AU2001276499A1 (en) Assay
AU3389501A (en) Assay
AU3292800A (en) Improved stage
AU6584600A (en) Retrovirus assay